Hai T. Tran

15.0k total citations · 1 hit paper
168 papers, 7.5k citations indexed

About

Hai T. Tran is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Hai T. Tran has authored 168 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Oncology, 64 papers in Pulmonary and Respiratory Medicine and 51 papers in Molecular Biology. Recurrent topics in Hai T. Tran's work include Lung Cancer Treatments and Mutations (45 papers), Cancer Genomics and Diagnostics (22 papers) and Lung Cancer Research Studies (19 papers). Hai T. Tran is often cited by papers focused on Lung Cancer Treatments and Mutations (45 papers), Cancer Genomics and Diagnostics (22 papers) and Lung Cancer Research Studies (19 papers). Hai T. Tran collaborates with scholars based in United States, Vietnam and China. Hai T. Tran's co-authors include John V. Heymach, Roy S. Herbst, Alan Sandler, David H. Johnson, David A. Ramies, Bruce E. Johnson, Timothy Madden, Róbert Hermann, Vincent A. Miller and L. Fehrenbacher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Hai T. Tran

163 papers receiving 7.3k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer

2005 1.2k citations Roy S. Herbst, Bruce E. Johnson et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hai T. Tran United States	42	3.5k	2.9k	2.9k	1.4k	808	168	7.5k
Takeshi Yuasa Japan	40	2.2k 0.6×	2.5k 0.9×	2.9k 1.0×	1.3k 0.9×	344 0.4×	318	6.3k
Go Watanabe Japan	51	2.5k 0.7×	3.3k 1.1×	2.5k 0.9×	868 0.6×	161 0.2×	515	9.9k
Yutaka Takahashi Japan	42	2.0k 0.6×	3.1k 1.1×	1.6k 0.6×	1.2k 0.9×	243 0.3×	305	8.1k
Pierre Major Canada	40	4.1k 1.1×	2.1k 0.7×	1.7k 0.6×	565 0.4×	547 0.7×	154	6.4k
Vikram Deshpande United States	76	5.9k 1.7×	5.0k 1.7×	2.9k 1.0×	1.9k 1.4×	422 0.5×	329	21.5k
Shinya Kimura Japan	45	2.1k 0.6×	2.6k 0.9×	1.1k 0.4×	683 0.5×	2.1k 2.6×	427	7.1k
Gene P. Siegal United States	58	4.4k 1.2×	5.3k 1.8×	2.9k 1.0×	1.9k 1.4×	304 0.4×	331	12.5k
Mark W. Lingen United States	51	2.0k 0.6×	2.8k 1.0×	1.3k 0.5×	1.2k 0.8×	205 0.3×	175	7.6k
Peiguo Chu United States	49	3.5k 1.0×	2.7k 0.9×	2.0k 0.7×	1.4k 1.0×	182 0.2×	151	8.6k
Christopher Poremba Germany	54	2.5k 0.7×	3.0k 1.0×	2.2k 0.8×	1.8k 1.3×	172 0.2×	166	7.7k

Countries citing papers authored by Hai T. Tran

Since Specialization

Citations

This map shows the geographic impact of Hai T. Tran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai T. Tran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai T. Tran more than expected).

Fields of papers citing papers by Hai T. Tran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hai T. Tran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai T. Tran. The network helps show where Hai T. Tran may publish in the future.

Co-authorship network of co-authors of Hai T. Tran

This figure shows the co-authorship network connecting the top 25 collaborators of Hai T. Tran. A scholar is included among the top collaborators of Hai T. Tran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hai T. Tran. Hai T. Tran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Piha‐Paul, Sarina A., Chieh Tseng, Hai T. Tran, et al.. (2025). Phase I trial of the combination of the pan-ErbB inhibitor neratinib and mTOR inhibitor everolimus in advanced cancer patients with ErbB family gene alterations. ESMO Open. 10(2). 104136–104136. 2 indexed citations

Grippin, Adam, Erin L. Young, Ellen T. Chang, et al.. (2024). 995MO Association of SARS-COV-2 mRNA vaccines with tumor PD-L1 expression and clinical responses to immune checkpoint blockade. Annals of Oncology. 35. S677–S678. 2 indexed citations

Duong, Thuc‐Huy, et al.. (2024). Alpha-glucosidase inhibitory compounds from Vietnamese lichen Usnea baileyi: in vitro and in silico aspects. RSC Advances. 14(44). 32624–32636. 2 indexed citations

Altan, Mehmet, Ziyi Li, Runzhe Chen, et al.. (2024). High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC. Journal for ImmunoTherapy of Cancer. 12(12). e008950–e008950. 5 indexed citations

Johnson, Faye M., Hai T. Tran, Alexandre Reuben, et al.. (2024). Phase I/II Study of the Aurora Kinase A Inhibitor Alisertib and Pembrolizumab in Refractory, Rb-Deficient Head and Neck Squamous Cell Carcinomas. Clinical Cancer Research. 31(3). 479–490. 2 indexed citations

Tran, Hai T., Simon Heeke, Sheeba J. Sujit, et al.. (2023). Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer. Annals of Oncology. 35(2). 183–189. 32 indexed citations

Patel, Sonia, Monique B. Nilsson, Yan Yang, et al.. (2023). IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC. Clinical Cancer Research. 29(7). 1292–1304. 62 indexed citations

Pham, Tien, et al.. (2022). Image Based Visual Servo Control with a Two-Axis Inertially Stabilized Platform Using Deep Deterministic Policy Gradient. 4. 31–37. 1 indexed citations

Fahrmann, Johannes F., Hiroyuki Katayama, Ehsan Irajizad, et al.. (2021). Plasma Based Protein Signatures Associated with Small Cell Lung Cancer. Cancers. 13(16). 3972–3972. 6 indexed citations

10.

William, William Nassib, Won‐Chul Lee, J. Jack Lee, et al.. (2019). Genomic and transcriptomic landscape of oral pre-cancers (OPCs) and risk of oral cancer (OC).. Journal of Clinical Oncology. 37(15_suppl). 6009–6009. 11 indexed citations

11.

Nilsson, Monique B., Uma Giri, Jayanthi Gudikote, et al.. (2015). KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI Vandetanib. Clinical Cancer Research. 22(8). 1940–1950. 10 indexed citations

12.

Groot, John de, Yuji Piao, Hai T. Tran, et al.. (2011). Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept. Clinical Cancer Research. 17(14). 4872–4881. 51 indexed citations

13.

Heymach, John V., Terry J. Shackleford, Hai T. Tran, et al.. (2011). Effect of Low-Fat Diets on Plasma Levels of NF-κB–Regulated Inflammatory Cytokines and Angiogenic Factors in Men with Prostate Cancer. Cancer Prevention Research. 4(10). 1590–1598. 43 indexed citations

14.

Zinner, Ralph, Elmira Popova, Paul Damien, et al.. (2009). Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells. Molecular Cancer Therapeutics. 8(3). 521–532. 48 indexed citations

15.

William, William N., J. Jack Lee, Scott M. Lippman, et al.. (2009). High-Dose Fenretinide in Oral Leukoplakia. Cancer Prevention Research. 2(1). 22–26. 33 indexed citations

16.

Kim, Edward S., Ann M. Mauer, William N. William, et al.. (2009). A phase 2 study of cetuximab in combination with docetaxel in chemotherapy‐refractory/resistant patients with advanced nonsmall cell lung cancer. Cancer. 115(8). 1713–1722. 27 indexed citations

17.

Sun, Hongxia, Wen-Cheng Chung, Zhenlin Ju, et al.. (2008). Cyclic AMP-Responsive Element Binding Protein– and Nuclear Factor-κB–Regulated CXC Chemokine Gene Expression in Lung Carcinogenesis. Cancer Prevention Research. 1(5). 316–328. 57 indexed citations

18.

Li, Zhong, Jonathon D. Roybal, Raghothama Chaerkady, et al.. (2008). Identification of Secreted Proteins that Mediate Cell-Cell Interactions in an In vitro Model of the Lung Cancer Microenvironment. Cancer Research. 68(17). 7237–7245. 68 indexed citations

19.

Beran, Miloslav, Susan O’Brien, Deborah A. Thomas, et al.. (2003). Phase I study of oral topotecan in hematological malignancies.. PubMed. 9(11). 4084–91. 9 indexed citations

20.

Russell, Jeffrey A., Hai T. Tran, Diana Quinlan, et al.. (2002). Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: Study of pharmacokinetics and early clinical outcomes. Biology of Blood and Marrow Transplantation. 8(9). 468–476. 220 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact